Prosecution Insights
Prosecution Insights
14 pending office actions • 10 art units • 14 examiners • 0 of 14 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 6 (43%) |
| §103 only | 2 (14%) |
| §112 only | 1 (7%) |
| Double-patenting + other | 2 (14%) |
| Multi-statute (no §101) | 3 (21%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAGOPIAN, CASEY SHEA | 1 | 54.4% | +33.3% |
| WRIGHT, ERIC BRANDON | 1 | — | — |
| MEYERING, SHABANA SHABBEER | 1 | 69.7% | +41.8% |
| POHNERT, STEVEN C | 1 | 12.2% | +18.7% |
| GOLDBERG, JEANINE ANNE | 1 | 45.9% | +40.9% |
| BUCHANAN, BAILEY CHEYENNE | 1 | 47.6% | +50.0% |
| DARRIGRAND, EMILY ANN | 1 | — | — |
| QIAN, CELINE X | 1 | 47.6% | +16.7% |
| RAMIREZ, DELIA M | 1 | 65.1% | +56.3% |
| YU, DAVID TUYANG | 1 | 100.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18006888 | BIOMARKERS FOR DIAGNOSING AND MONITORING LUNG CANCER | BUCHANAN, BAILEY CHEYENNE | 100d overdue |
| 18273389 | A Method for Diagnosing Endometrial or Ovarian Carcinoma | GOLDBERG, JEANINE ANNE | 23d overdue |
| 17917953 | ANTISENSE SEQUENCES FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS | YU, DAVID TUYANG | 3d overdue |
| 18009731 | A CELLULAR MARKER OF COVID SEVERITY | QIAN, CELINE X | 28d |
| 18554161 | METHODS AND KITS FOR DIAGNOSING CANCER AND PREDICTING RESPONSE TO TREATMENT BASED ON CENP-A LABELLING | POHNERT, STEVEN C | — |
| 18006030 | TRAINING METHOD AND MODEL FOR PREDICTING INHIBITORS OF DRUGS METABOLIZING ENZYMES | DARRIGRAND, EMILY ANN | — |
| 17926160 | USE OF A FUSION PROTEIN FOR INDUCING GENETIC MODIFICATIONS BY TARGETED MEIOTIC RECOMBINATION | RAMIREZ, DELIA M | — |
| 17790075 | PH SENSOR DEVICE INTENDED TO BE INSERTED INTO THE GROUND, METHOD FOR MEASURING PH, IN PARTICULAR FOR CATHODIC PROTECTION | JEBUTU, MOFOLUWASO SIMILOLUWA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18006888 | BIOMARKERS FOR DIAGNOSING AND MONITORING LUNG CANCER | BUCHANAN, BAILEY CHEYENNE | 100d overdue |
| 18273389 | A Method for Diagnosing Endometrial or Ovarian Carcinoma | GOLDBERG, JEANINE ANNE | 23d overdue |
| 18009731 | A CELLULAR MARKER OF COVID SEVERITY | QIAN, CELINE X | 28d |
| 18849368 | COMPOSITIONS FOR USE AS DENTINE SUBSTITUTE | HAGOPIAN, CASEY SHEA | — |
| 18287758 | COMPOSITIONS AND METHODS FOR TREATING RETINAL DEGENERATIVE DISORDERS | MEYERING, SHABANA SHABBEER | — |
| 18554161 | METHODS AND KITS FOR DIAGNOSING CANCER AND PREDICTING RESPONSE TO TREATMENT BASED ON CENP-A LABELLING | POHNERT, STEVEN C | — |
| 17926160 | USE OF A FUSION PROTEIN FOR INDUCING GENETIC MODIFICATIONS BY TARGETED MEIOTIC RECOMBINATION | RAMIREZ, DELIA M | — |
| Art Unit | Apps |
|---|---|
| 1635 | 2 |
| 1682 | 2 |
| 1632 | 1 |
| 1683 | 1 |
| 1637 | 1 |
| 1652 | 1 |
| 1795 | 1 |
| 1638 | 1 |
| 3791 | 1 |
| 1728 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18849368 | COMPOSITIONS FOR USE AS DENTINE SUBSTITUTE | HAGOPIAN, CASEY SHEA | — | §112DP | Non-Final OA | — | Pending | Sep 20, 2024 |
| 18491138 | G-PROTEIN-GATED-K+ CHANNEL-MEDIATED ENHANCEMENTS IN LIGHT SENSITIVITY IN ROD-CONE DYSTROPHY (RCD) | WRIGHT, ERIC BRANDON | 1632 | §102§103§112DP | Non-Final OA | — | Pending | Oct 20, 2023 |
| 18287758 | COMPOSITIONS AND METHODS FOR TREATING RETINAL DEGENERATIVE DISORDERS | MEYERING, SHABANA SHABBEER | 1635 | §103 | Non-Final OA | — | Pending | Oct 20, 2023 |
| 18554161 | METHODS AND KITS FOR DIAGNOSING CANCER AND PREDICTING RESPONSE TO TREATMENT BASED ON CENP-A LABELLING | POHNERT, STEVEN C | 1683 | §101§103§112 | Non-Final OA | — | Pending | Oct 05, 2023 |
| 18273389 | A Method for Diagnosing Endometrial or Ovarian Carcinoma | GOLDBERG, JEANINE ANNE | 1682 | §101§102§112 | Final Rejection | 23d overdue | Pending | Jul 20, 2023 |
| 18006888 | BIOMARKERS FOR DIAGNOSING AND MONITORING LUNG CANCER | BUCHANAN, BAILEY CHEYENNE | 1682 | §101§102§103§112 | Final Rejection | 100d overdue | Pending | Jan 26, 2023 |
| 18006030 | TRAINING METHOD AND MODEL FOR PREDICTING INHIBITORS OF DRUGS METABOLIZING ENZYMES | DARRIGRAND, EMILY ANN | — | §101§102§103§112 | Non-Final OA | — | Pending | Jan 19, 2023 |
| 18009731 | A CELLULAR MARKER OF COVID SEVERITY | QIAN, CELINE X | 1637 | §101§102§103§112 | Non-Final OA | 28d | Pending | Dec 11, 2022 |
| 17926160 | USE OF A FUSION PROTEIN FOR INDUCING GENETIC MODIFICATIONS BY TARGETED MEIOTIC RECOMBINATION | RAMIREZ, DELIA M | 1652 | §103§112Other | Final Rejection | — | Pending | Nov 18, 2022 |
| 17917953 | ANTISENSE SEQUENCES FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS | YU, DAVID TUYANG | 1635 | §101§102§103§112 | Non-Final OA | 3d overdue | Pending | Oct 10, 2022 |
| 17790075 | PH SENSOR DEVICE INTENDED TO BE INSERTED INTO THE GROUND, METHOD FOR MEASURING PH, IN PARTICULAR FOR CATHODIC PROTECTION | JEBUTU, MOFOLUWASO SIMILOLUWA | 1795 | §103§112 | Final Rejection | — | Pending | Jun 29, 2022 |
| 17768002 | GENETICALLY MODIFIED HUMAN STEM CELL EXPRESSING A MUTANT HUMAN CYTOCHROME P450 2B6 PROTEIN AND ITS USE THEREOF IN THE TREATMENT OF CANCER | BURKHART, MICHAEL D | 1638 | §112 | Final Rejection | — | Pending | Apr 11, 2022 |
| 17766311 | SYSTEM FOR THE AUTOMATIC EVALUATION OF COGNITION AND CONSCIOUSNESS OF AN INDIVIDUAL THROUGH EXTERNAL STIMULATIONS | GOMES, SRISTI DIVINA | 3791 | §103§112 | Final Rejection | — | Pending | Apr 04, 2022 |
| 17622065 | LAYERED ACTIVE MATERIAL FOR NA-ION BATTERIES | ALBAN, FELICITY BERNARD | 1728 | §103 | Final Rejection | — | Pending | Dec 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial